These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 12509012)

  • 1. Evidence of upward spread of suppression in DPOAE measurements.
    Gorga MP; Neely ST; Dorn PA; Dierking D; Cyr E
    J Acoust Soc Am; 2002 Dec; 112(6):2910-20. PubMed ID: 12509012
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The use of distortion product otoacoustic emission suppression as an estimate of response growth.
    Gorga MP; Neely ST; Dorn PA; Konrad-Martin D
    J Acoust Soc Am; 2002 Jan; 111(1 Pt 1):271-84. PubMed ID: 11831801
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distortion product otoacoustic emission suppression tuning curves in normal-hearing and hearing-impaired human ears.
    Gorga MP; Neely ST; Dierking DM; Dorn PA; Hoover BM; Fitzpatrick DF
    J Acoust Soc Am; 2003 Jul; 114(1):263-78. PubMed ID: 12880040
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cochlear compression estimates from measurements of distortion-product otoacoustic emissions.
    Neely ST; Gorga MP; Dorn PA
    J Acoust Soc Am; 2003 Sep; 114(3):1499-507. PubMed ID: 14514203
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The influence of systematic primary-tone level variation L2-L1 on the acoustic distortion product emission 2f1-f2 in normal human ears.
    Hauser R; Probst R
    J Acoust Soc Am; 1991 Jan; 89(1):280-6. PubMed ID: 2002169
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Repeatability of high-frequency distortion-product otoacoustic emissions in normal-hearing adults.
    Dreisbach LE; Long KM; Lees SE
    Ear Hear; 2006 Oct; 27(5):466-79. PubMed ID: 16957498
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Further efforts to predict pure-tone thresholds from distortion product otoacoustic emission input/output functions.
    Gorga MP; Neely ST; Dorn PA; Hoover BM
    J Acoust Soc Am; 2003 Jun; 113(6):3275-84. PubMed ID: 12822800
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sources of DPOAEs revealed by suppression experiments, inverse fast Fourier transforms, and SFOAEs in impaired ears.
    Konrad-Martin D; Neely ST; Keefe DH; Dorn PA; Cyr E; Gorga MP
    J Acoust Soc Am; 2002 Apr; 111(4):1800-9. PubMed ID: 12002864
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 2f1-f2 distortion product otoacoustic emissions in White Leghorn chickens (Gallus domesticus): effects of frequency ratio and relative level.
    Burkard R; Salvi R; Chen L
    Audiol Neurootol; 1996; 1(4):197-213. PubMed ID: 9390802
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The influence of common stimulus parameters on distortion product otoacoustic emission fine structure.
    Johnson TA; Baranowski LG
    Ear Hear; 2012; 33(2):239-49. PubMed ID: 21918451
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fine structure of distortion product otoacoustic emissions: its dependence on age and hearing threshold and clinical implications.
    Wagner W; Plinkert PK; Vonthein R; Plontke SK
    Eur Arch Otorhinolaryngol; 2008 Oct; 265(10):1165-72. PubMed ID: 18301908
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Frequency responses of two- and three-tone distortion product otoacoustic emissions in Mongolian gerbils.
    Mills DM
    J Acoust Soc Am; 2000 May; 107(5 Pt 1):2586-602. PubMed ID: 10830382
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pure-tone threshold estimation from extrapolated distortion product otoacoustic emission I/O-functions in normal and cochlear hearing loss ears.
    Boege P; Janssen T
    J Acoust Soc Am; 2002 Apr; 111(4):1810-8. PubMed ID: 12002865
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of primary-level and primary-frequency ratios on human distortion product otoacoustic emissions.
    Johnson TA; Neely ST; Garner CA; Gorga MP
    J Acoust Soc Am; 2006 Jan; 119(1):418-28. PubMed ID: 16454296
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical test performance of distortion-product otoacoustic emissions using new stimulus conditions.
    Johnson TA; Neely ST; Kopun JG; Dierking DM; Tan H; Gorga MP
    Ear Hear; 2010 Feb; 31(1):74-83. PubMed ID: 19701088
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Use of acoustic distortion products in clinical diagnosis. The site of origin of otoacoustic emissions in the inner ear].
    Plinkert PK; Harris FP; Probst R
    HNO; 1993 Jul; 41(7):339-44. PubMed ID: 8376180
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A new procedure for measuring peripheral compression in normal-hearing and hearing-impaired listeners.
    Nelson DA; Schroder AC; Wojtczak M
    J Acoust Soc Am; 2001 Oct; 110(4):2045-64. PubMed ID: 11681384
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-Frequency Distortion-Product Otoacoustic Emission Repeatability in a Patient Population.
    Dreisbach L; Zettner E; Chang Liu M; Meuel Fernhoff C; MacPhee I; Boothroyd A
    Ear Hear; 2018; 39(1):85-100. PubMed ID: 28678077
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distortion product otoacoustic emission suppression tuning curves in human adults and neonates.
    Abdala C; Sininger YS; Ekelid M; Zeng FG
    Hear Res; 1996 Sep; 98(1-2):38-53. PubMed ID: 8880180
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suppression tuning characteristics of the 2 f1-f2 distortion-product otoacoustic emission in humans.
    Kummer P; Janssen T; Arnold W
    J Acoust Soc Am; 1995 Jul; 98(1):197-210. PubMed ID: 7608400
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.